INVITE-ME: IN VItro T-cell Engineering with Megakaryocyte EVs
STRM.BIO, Inc. in Cambridge, Mass. seeks to develop a novel delivery platform to transport therapeutic cargo to immune cells and treat autoimmune diseases
STRM.BIO, Inc. in Cambridge, Mass. seeks to develop a novel delivery platform to transport therapeutic cargo to immune cells and treat autoimmune diseases